CME CirclePrint this Activity for Offline ReferenceInstructions on Taking Medscape CME

Great Debates in Gynecologic Oncology CME
Course Director: Thomas J. Herzog, MD; Faculty: Maurie Markman, MD; Tate Thigpen, MD; Peter Rose, MD; Robert Nagourney, MD; Bradley J. Monk, MD
Disclosures

Release Date: June 13, 2003; Valid for credit through June 13, 2004

This activity has expired.
CME in this activity indicates that it was developed according to ACCME guidelines and was certified for credit by one or more accredited CME or CE providers. Medscape cannot attest to the timeliness of expired CME activities.


This CME activity, "Great Debates in Gynecologic Oncology" was originally offered as a monograph certified for CME.

Contents of This CME Activity
  1. Case 1: Front-Line Therapy of Ovarian Cancer
    Case
    Discussant 1: Maurie Markman, MD
    Discussant 2: Tate Thigpen, MD

  2. Case 2: Recurrent Ovarian Cancer Five Months Following Carboplatin/Paclitaxel Therapy
    Case
    Discussant 1: Thomas J. Herzog, MD
    Discussant 2: Peter Rose, MD

  3. Case 3: Use of Sensitivity Assays in Ovarian Cancer
    Case
    Discussant 1: Bob Nagourney, MD
    Discussant 2: Maurie Markman, MD

  4. Case 4: Management of Advanced Cervical Cancer
    Case
    Discussant 1: Bradley J. Monk, MD
    Discussant 2: Tate Thigpen, MD

These educational activities, certified by accredited providers, were not prepared by Medscape's editors, but are made available on our site as a service to our audience. Authors are routinely instructed by the provider to disclose significant financial relationships and mention of investigational drugs and unapproved indications. Medscape has received a fee for posting these activities. Direct questions or comments to: CME@webmd.net.

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape, The University of Alabama School of Medicine, the companies providing educational grants or the authors and writers. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. All readers and continuing education participants should verify all information and consult a qualified healthcare professional before treating patients or utilizing any therapeutic product discussed in this educational activity.

 
Copyright © 2003 The Network for Oncology Communication and Research.
Lilly
  • This activity has expired.

    The accredited provider can no longer issue certificates for this activity. Medscape cannot attest to the timeliness of expired CME activities.

  • CME Information
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.